You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cipro In Dextrose 5% In Plastic Container, and what generic alternatives are available?

Cipro In Dextrose 5% In Plastic Container is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cipro In Dextrose 5% In Plastic Container

A generic version of CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-001 Dec 26, 1990 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-002 Dec 26, 1990 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-001 Dec 26, 1990 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-001 Dec 26, 1990 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-001 Dec 26, 1990 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019857-001 Dec 26, 1990 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

See the table below for patents covering CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER around the world.

Country Patent Number Title Estimated Expiration
Hungary 194733 PROCESS FOR PRODUCING LACTATE SOLUTIONS OF PIPERAZINYL-QUINOLONE- AND PIPERAZINYL-AZAQUINOLONE-CARBOXYLIC ACIDS ⤷  Sign Up
Portugal 83588 PROCESSO PARA A PREPARACAO DE SOLUCOES INFUSAO DE ACIDO 1-CICLOPROPIL-6-FLUORO-1,4-DI-HIDRO-4-OXO-7-(1-PIPERAZINIL)-QUINOLINO-3-CARBOXILICO ⤷  Sign Up
U.S.S.R. 1487801 СПОСОБ ПОЛУЧЕНИЯ АНТИБАКТЕРИАЛЬНОГО СРЕДСТВА (METHOD OF PRODUCING ANTIBACTERIAL COMPOSITION) ⤷  Sign Up
German Democratic Republic 252125 VERFAHREN ZUR HERSTELLUNG VON INFUSIONSLOESUNGEN DER 1-CYCLOPROPYL-6-FLUR-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-CHINOLIN-3-CARBONSAEURE ⤷  Sign Up
Australia 7468081 ⤷  Sign Up
Japan S5777683 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO- NAPHTHYRIDINE-3-CARBOXYLIC ACIDS OR SALTS THEREOF, MANUFACTURE AND ANTIBACTERIAL THEREOF AS ACTIVE INGREDIENT ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1429780 SPC/GB12/058 United Kingdom ⤷  Sign Up PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
1429780 122012000070 Germany ⤷  Sign Up PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808
1429780 132013902137451 Italy ⤷  Sign Up PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106
1429780 13C0012 France ⤷  Sign Up PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.